Welcome to our dedicated page for CARECLOUD SEC filings (Ticker: CCLDO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CareCloud, Inc. 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (CCLDO) filings page on Stock Titan is designed to help investors connect the company’s regulatory disclosures with the terms and performance of this preferred security. While no specific SEC filings are listed in the provided data set, CareCloud’s public communications give a clear picture of the types of information that typically appear in its formal reports and offering documents.
For CCLDO, investors generally look to SEC filings such as registration statements, prospectuses, and periodic reports for the full legal description of the Series B Preferred Stock. These documents explain the 8.75% annual dividend rate based on a $25.00 per share liquidation preference, the cumulative nature of dividends, the monthly payment schedule, and the rights of holders in various scenarios. They also detail the issuer’s redemption options, including step-down redemption prices over time and redemption rights upon a Change of Control, as described in CareCloud’s dividend and capital markets announcements.
Company filings also typically provide context on CareCloud’s broader healthcare technology and AI business, including revenue cycle management, practice management, electronic health records, business intelligence, patient experience management, digital health, and AI initiatives. In its earnings releases and financial summaries, CareCloud has discussed revenue trends, profitability, acquisitions such as Medsphere’s hospital IT business and HFMA’s MAP App, and the role of its AI Center of Excellence. These topics are often expanded upon in Forms 10-K and 10-Q, along with risk factors, capital structure details, and discussions of preferred stock dividends and arrears.
On Stock Titan, AI-powered tools can help users interpret complex filing language related to CCLDO. Summaries can highlight key terms of the Series B Preferred Stock, such as dividend rights, redemption mechanics, and priority relative to common stock, as well as draw attention to sections of annual and quarterly reports that discuss preferred dividends, arrears plans, and financing strategies. Investors can also use filing data to cross-reference CareCloud’s press releases about dividend declarations, arrears catch-up plans, and redemption options with the formal terms set out in the Certificate of Designations and other governing documents.
By reviewing CareCloud’s SEC filings alongside its news releases, investors gain a more complete view of how the CCLDO preferred stock fits within the company’s capital structure and how its income features relate to the performance of CareCloud’s healthcare technology and AI platform.
CareCloud, Inc. intends to sell up to $60,000,000 of common stock through an At-The-Market offering under an At The Market Offering Agreement dated April 13, 2026 with Citizens JMP Securities, LLC. Sales may occur from time to time on the Nasdaq or in other permitted transaction types as an “at-the-market offering.” The placement agent fee is 3.0% of gross proceeds and Citizens will be deemed an underwriter for Securities Act purposes. Net proceeds, if any, will be used for working capital and general corporate purposes, which may include acquisitions, debt repayment, capital expenditures and redemption of preferred stock.
CareCloud, Inc. intends to sell up to $60,000,000 of common stock through an At-The-Market offering under an At The Market Offering Agreement dated April 13, 2026 with Citizens JMP Securities, LLC. Sales may occur from time to time on the Nasdaq or in other permitted transaction types as an “at-the-market offering.” The placement agent fee is 3.0% of gross proceeds and Citizens will be deemed an underwriter for Securities Act purposes. Net proceeds, if any, will be used for working capital and general corporate purposes, which may include acquisitions, debt repayment, capital expenditures and redemption of preferred stock.
CareCloud, Inc. entered into a new Credit Agreement providing a $40 million term loan and a $10 million revolving credit facility maturing on the fourth anniversary of closing. The loans are secured by substantially all company and subsidiary assets and carry interest based on SOFR or an alternate base rate plus a margin.
As part of the collateral package, Executive Chairman Mahmud Haq will pledge certain securities accounts and receive a five-year warrant exercisable for 4,300,000 common shares at $5.00 per share. The company also put in place an at-the-market equity program to sell up to $60 million of common stock through Citizens JMP Securities.
CareCloud elected to redeem all 1,511,372 outstanding shares of its 8.75% Series B Preferred Stock on May 15, 2026 at $25.25 per share plus $2.27 of accrued dividends, for total cash of $27.52 per share. The redemption is expected to eliminate approximately $3.2 million in annual preferred dividends; management notes the company generates about $30 million in annualized adjusted EBITDA.
CareCloud, Inc. entered into a new Credit Agreement providing a $40 million term loan and a $10 million revolving credit facility maturing on the fourth anniversary of closing. The loans are secured by substantially all company and subsidiary assets and carry interest based on SOFR or an alternate base rate plus a margin.
As part of the collateral package, Executive Chairman Mahmud Haq will pledge certain securities accounts and receive a five-year warrant exercisable for 4,300,000 common shares at $5.00 per share. The company also put in place an at-the-market equity program to sell up to $60 million of common stock through Citizens JMP Securities.
CareCloud elected to redeem all 1,511,372 outstanding shares of its 8.75% Series B Preferred Stock on May 15, 2026 at $25.25 per share plus $2.27 of accrued dividends, for total cash of $27.52 per share. The redemption is expected to eliminate approximately $3.2 million in annual preferred dividends; management notes the company generates about $30 million in annualized adjusted EBITDA.
CareCloud, Inc. is asking shareholders to vote at its June 4, 2026 annual meeting on director elections, executive pay, a new 2026 Equity Incentive Plan, and ratification of Tanner LLP as auditor for 2026.
The proxy describes governance structures, board and committee activity, and detailed director and executive compensation, including 2025 salaries such as $300,000 for Executive Chairman Mahmud Haq and co-CEOs. It also outlines related-party arrangements, including leases with the Executive Chairman and consulting agreements with family members and a director-controlled entity. The new 2026 Equity Incentive Plan would authorize up to 1,000,000 shares for future equity awards alongside existing plan reserves.
CareCloud, Inc. is asking shareholders to vote at its June 4, 2026 annual meeting on director elections, executive pay, a new 2026 Equity Incentive Plan, and ratification of Tanner LLP as auditor for 2026.
The proxy describes governance structures, board and committee activity, and detailed director and executive compensation, including 2025 salaries such as $300,000 for Executive Chairman Mahmud Haq and co-CEOs. It also outlines related-party arrangements, including leases with the Executive Chairman and consulting agreements with family members and a director-controlled entity. The new 2026 Equity Incentive Plan would authorize up to 1,000,000 shares for future equity awards alongside existing plan reserves.
CareCloud, Inc. reported a board change affecting its audit committee. On March 24, 2026, the board appointed Cameron Munter to serve as a member of the Audit Committee. The board determined he meets Nasdaq’s independence requirements, so the Audit Committee now has three independent directors and the company has regained compliance with Nasdaq Listing Rule 5605(c)(2). Nasdaq has notified the company that it is back in compliance with this rule.
CareCloud, Inc. reported a board change affecting its audit committee. On March 24, 2026, the board appointed Cameron Munter to serve as a member of the Audit Committee. The board determined he meets Nasdaq’s independence requirements, so the Audit Committee now has three independent directors and the company has regained compliance with Nasdaq Listing Rule 5605(c)(2). Nasdaq has notified the company that it is back in compliance with this rule.
CareCloud, Inc. files its annual report describing its technology-enabled revenue cycle management, cloud software and expanding generative AI solutions for U.S. healthcare providers. The company relies heavily on offshore operations in Pakistan and Sri Lanka, where roughly 3,300 staff support its cost advantage.
As of June 30, 2025, non‑affiliate common equity had an aggregate market value of about $85.1 million, and at March 6, 2026 there were 42,492,949 common shares outstanding. The filing highlights extensive business, cybersecurity, regulatory and macro risks, including past suspension and later resumption of preferred dividends, ongoing arrears, and dilution from a March 2025 conversion of most Series A preferred into common stock.
CareCloud, Inc. files its annual report describing its technology-enabled revenue cycle management, cloud software and expanding generative AI solutions for U.S. healthcare providers. The company relies heavily on offshore operations in Pakistan and Sri Lanka, where roughly 3,300 staff support its cost advantage.
As of June 30, 2025, non‑affiliate common equity had an aggregate market value of about $85.1 million, and at March 6, 2026 there were 42,492,949 common shares outstanding. The filing highlights extensive business, cybersecurity, regulatory and macro risks, including past suspension and later resumption of preferred dividends, ongoing arrears, and dilution from a March 2025 conversion of most Series A preferred into common stock.
CareCloud director Lawrence S. Sharnak reported an equity award vesting and share issuance. On February 8, 2026, 7,500 restricted stock units converted into 7,500 shares of CareCloud common stock at a price of $0. According to the filing, these restricted stock units and the resulting shares were granted under the company’s Amended and Restated Equity Incentive Plan without payment by Sharnak.
Following the transaction, Sharnak directly owned 127,750 shares of common stock and 26,250 restricted stock units. This reflects routine compensation-related activity rather than an open-market purchase or sale.
CareCloud director Lawrence S. Sharnak reported an equity award vesting and share issuance. On February 8, 2026, 7,500 restricted stock units converted into 7,500 shares of CareCloud common stock at a price of $0. According to the filing, these restricted stock units and the resulting shares were granted under the company’s Amended and Restated Equity Incentive Plan without payment by Sharnak.
Following the transaction, Sharnak directly owned 127,750 shares of common stock and 26,250 restricted stock units. This reflects routine compensation-related activity rather than an open-market purchase or sale.
CareCloud, Inc. director Cameron Munter reported a routine equity compensation vesting. On February 8, 2026, 7,500 restricted stock units converted into 7,500 shares of common stock at a price of $0 per share, under the company’s Amended and Restated Equity Incentive Plan.
After this conversion, Munter directly beneficially owned 202,750 shares of CareCloud common stock and 26,250 restricted stock units. The transaction involved no cash payment by the reporting person and reflects standard compensation-based vesting rather than an open‑market purchase or sale.
CareCloud, Inc. director Cameron Munter reported a routine equity compensation vesting. On February 8, 2026, 7,500 restricted stock units converted into 7,500 shares of common stock at a price of $0 per share, under the company’s Amended and Restated Equity Incentive Plan.
After this conversion, Munter directly beneficially owned 202,750 shares of CareCloud common stock and 26,250 restricted stock units. The transaction involved no cash payment by the reporting person and reflects standard compensation-based vesting rather than an open‑market purchase or sale.
CareCloud, Inc. director Anne Busquet reported the vesting and conversion of 7,500 restricted stock units into common stock on February 8, 2026. The RSUs and resulting shares were issued under the company’s Amended and Restated Equity Incentive Plan without any cash payment by her.
After this equity award vesting, she directly holds 295,138 shares of CareCloud common stock and 26,250 derivative securities in the form of restricted stock units.
CareCloud, Inc. director Anne Busquet reported the vesting and conversion of 7,500 restricted stock units into common stock on February 8, 2026. The RSUs and resulting shares were issued under the company’s Amended and Restated Equity Incentive Plan without any cash payment by her.
After this equity award vesting, she directly holds 295,138 shares of CareCloud common stock and 26,250 derivative securities in the form of restricted stock units.
CareCloud, Inc. director Bill Korn reported the vesting and conversion of 7,500 restricted stock units into common stock on February 8, 2026. The RSUs and resulting shares were issued under the company’s Amended and Restated Equity Incentive Plan without any cash payment by Korn.
After this transaction, Korn beneficially owns 211,633 shares of CareCloud common stock directly and 26,250 restricted stock units, reflecting his ongoing equity-based compensation as a director.
CareCloud, Inc. director Bill Korn reported the vesting and conversion of 7,500 restricted stock units into common stock on February 8, 2026. The RSUs and resulting shares were issued under the company’s Amended and Restated Equity Incentive Plan without any cash payment by Korn.
After this transaction, Korn beneficially owns 211,633 shares of CareCloud common stock directly and 26,250 restricted stock units, reflecting his ongoing equity-based compensation as a director.
CareCloud, Inc. director Bill Korn reported the vesting of equity awards and related share issuance. On January 31, 2026, 6,250 restricted stock units converted into 6,250 shares of common stock at a price of $0.00 under the company’s Amended and Restated Equity Incentive Plan, without payment by Korn. Following this transaction, he directly owned 204,133 shares of common stock and 33,750 restricted stock units.
CareCloud, Inc. director Bill Korn reported the vesting of equity awards and related share issuance. On January 31, 2026, 6,250 restricted stock units converted into 6,250 shares of common stock at a price of $0.00 under the company’s Amended and Restated Equity Incentive Plan, without payment by Korn. Following this transaction, he directly owned 204,133 shares of common stock and 33,750 restricted stock units.